Trevi Therapeutics(TRVI)
NEW HAVEN, CTBiotechnology
Focus: Trevi Therapeutics is a public biotech company focused on small-molecule therapies for respiratory, dermatology, and neurology indications. The company operates as a clinical-stage player with a concentrated pipeline centered on nalbuphine ER formulations.
Profile data last refreshed 14h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
2
Should You Work at Trevi Therapeutics?
AI assessmentSuitable for early-career scientists or commercial professionals seeking equity upside and direct ownership of clinical assets, but not for those prioritizing stability or rapid team scaling.
Why Work Here
- Focused pipeline with multiple Phase 2/3 programs in pruritus and respiratory disease—clear clinical focus reduces strategic uncertainty.
Data completeness
5/9 — Partial
Company HealthSolid
Pipeline
Early-stage
14 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Exoskeleton-Assisted Gait Training
Severe StrokeClinical Trials (1)
NCT03395717Stroke Rehabilitation With Exoskeleton-assisted Gait.
N/AHelp build intelligence for Trevi Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.